2 April 2025

Last updated: Sunday 30 March 2025

Research Directory

A start-up genomics company explains why open-source software is important

Time to engage with stem-cell therapy

Interview: 4-Antibody AG - How do you structure a biotech for divestment?

A Big Pharma deal that shares risk and reward

Focus on ophthalmology: new treatment modality

Due diligence is more than a numbers game

Kymab unlocks the power of the mouse

The role of technology providers in biotech

Risk sharing with Pharma -- is this the way to go?

Partnering with Russia